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In a recent review article we reconsidered the hypothesis
that neurogenic vasodilatation is a key factor in the genesis
of the headache of the migraine attack according to an
updated and critical analysis of past and current literature.
Cited papers span from pioneering studies in experimental
animals of more than a century ago, to very recent inves-
tigations in humans in whom vasodilatation of cranial
arteries has been accurately measured with highly sophis-
ticated and reliable techniques. Results of neurovascular
imaging studies have strongly corroborated previous
pharmacological acquisition with antagonists of the calci-
tonin gene-related peptide receptor. Findings from clinical
trials with these drugs underlined the role of neurogenic
vasodilatation in migraine. In a comment to our review [1],
Elliot Shevel [2] has appropriately noted that Zwetsloot
et al. [3] and Schoonman et al. [4] indeed studied the
middle cerebral artery and intracranial vessels and the last
10 mm of the external carotid artery. Dr. Shevel also noted
that the papers by Ashina et al. [5] and Wienecke et al. [6]
were performed in healthy volunteers in whom headache
and not migraine-like pain was studied. Thus, all these
ﬁndings do not negate the proposal by Graham and Woolf
(sustained in our review article) that pertains to migrai-
neurs and to the temporal artery (possibly limited to other
extracranial arteries). Therefore, we thank Dr. Shevel for
his observations that further support the view that vasodi-
latation brought about by activation of perivascular pepti-
dergic nerve ﬁbers should be considered as a major
mechanism in migraine. This was, in fact, the main purpose
of our review article.
On the other hand, we acknowledge that the complex
pathophysiology of migraine and the mystery that still
covers the initiating factors/mechanisms of the migraine
attack should cast caution in refusing the contribution of
triggers located in the central nervous system.
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